Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators.

@article{Pfeffer1995CholesterolAR,
  title={Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators.},
  author={Marc Pfeffer and Frank M. Sacks and Lemuel A. Moye and Lynn E. Brown and Jean Lucien Rouleau and Loren Howard Hartley and Richard Grimm and François Sestier and William J Wickemeyer},
  journal={The American journal of cardiology},
  year={1995},
  volume={76 9},
  pages={98C-106C}
}
Although elevated plasma cholesterol levels represent a well-established and significant risk for developing atherosclerosis, there is a wide spectrum of cholesterol levels in patients with coronary artery disease (CAD). Most secondary prevention studies have generated convincing evidence that cholesterol reduction in patients with high cholesterol levels is associated with improved clinical outcome by reducing risk of further cardiovascular events. However, other risk factors may play a… CONTINUE READING